Objective: The aim of this study was to assess the potential impact of the pharmacogenetic variability of CYP2B6 and ABCB1 genes on the pharmacokinetics of mitotane.

Methods: A retrospective analysis was carried out on 27 patients with adrenocortical carcinoma on postoperative adjunctive mitotane. CYP2B6 and ABCB1 polymorphisms were genotyped and tested for an association with plasma trough concentration after 3, 6, 9, and 12 months of therapy.

Results: Patients with the GT/TT genotype had higher mitotane plasma concentrations compared with patients with GG at 3 months (14.80 vs. 8.01 μg/ml; P=0.008) and 6 months (17.70 vs. 9.75 μg/ml; P=0.015). Multivariate logistic regression analysis showed that only the CYP2B6 rs3745274GT/TT genotype (odds ratio=10.7; P=0.017) was a predictor of mitotane plasma concentrations of at least 14 µg/ml after 3 months of treatment. Mitotane concentrations were not influenced by the polymorphisms of the ABCB1 gene.

Conclusion: Evaluation of the CYP2B6 polymorphism enabled prediction of the individual response to adjuvant mitotane treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e3283606cb2DOI Listing

Publication Analysis

Top Keywords

cyp2b6 polymorphism
8
cyp2b6 abcb1
8
mitotane plasma
8
plasma concentrations
8
mitotane
6
influence cyp2b6
4
polymorphism pharmacokinetics
4
pharmacokinetics mitotane
4
mitotane objective
4
objective aim
4

Similar Publications

Inter-individual variability in drug responses is significantly influenced by genetic factors, underscoring the importance of population-specific pharmacogenomic studies to optimize clinical outcomes. In this study, we analyzed whole genome sequencing data from 949 unrelated Thai individuals and conducted an in-depth analysis of 3239 genes involved in drug pharmacokinetics, pharmacodynamics, or immune-mediated adverse drug reactions. We identified 43 single nucleotide polymorphisms (SNPs), 134 diplotypes, and 15 human leukocyte antigen (HLA) alleles, all with moderate to high clinical significance.

View Article and Find Full Text PDF
Article Synopsis
  • Production of polychlorinated biphenyls (PCBs) has been banned since 2001, but health risks from exposure continue due to their metabolism by enzymes like CYP2B6, where gene polymorphisms may influence this process.
  • The study analyzed blood samples from 129 individuals to explore the relationship between specific CYP2B6 gene variants and levels of PCBs and their metabolites (OH-PCBs), finding variations in metabolism linked to different genotypes, particularly *1/*4 and *6/*6.
  • Results showed that the *1/*4 genotype was correlated with higher metabolite-to-parent compound ratios for certain PCBs, while the *6/*6 genotype showed the opposite effect, indicating complex interactions between genetic factors
View Article and Find Full Text PDF

Pharmacogenomic variation and sedation outcomes during early intensive care unit admission: A pragmatic study.

Clin Transl Sci

December 2024

Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.

Unpredicted responses to sedatives and analgesics are common in critically ill patients on mechanical ventilation (MV) and may be attributed to genetic variation. Our primary aim was to investigate the association between the pharmacogenomic (PGx) variation and sedation outcomes. The secondary aim was to capture intensive care unit (ICU) participants' perceptions of PGx.

View Article and Find Full Text PDF

Background: Genetic variants in absorption, distribution, metabolism, and excretion (ADME) genes affect drug efficacy and side effects. Whole-exome sequencing (WES) effectively identifies these variants. Findings from Western populations may not apply to the Han Chinese population due to ethnic differences.

View Article and Find Full Text PDF

Introduction: Confusion regarding methadone metabolism exists, hampering optimal clinical use. A systematic review was conducted to assess the impacts of cytochrome P450 (CYP) genetic polymorphisms on methadone outcomes.

Methods: MEDLINE, EMBASE, Web of Science, PsycINFO, and CENTRAL were searched to identify studies reporting methadone dose-adjusted plasma concentrations, clearance, maintenance dose, or treatment response in relation to polymorphisms in humans.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!